Coherus Oncology Inc (CHRS)

Gross Margin

70.35%

Quarterly · Period ending:

CHRS logo

CHRS Gross Margin

Latest reported70.35%
CHRS Quarterly Gross Margin (-1610.67% → 70.35%)
High-resolution chart · PNG

CHRS gross margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Gross Margin — Quarterly
Period endingGross Margin
70.3502%
61.8603%
61.241%
59.4936%
56.9826%
51.3225%
37.4668%
70.694%
54.5161%
37.6516%
7.6013%
56.1434%
57.681%
47.9776%
68.685%
22.4331%
81.2522%
84.4132%
83.503%
74.207%
80.95%
90.9543%
89.4284%
92.074%
92.5269%
94.0997%
93.6983%
94.2275%
99.2797%
94.0024%
0%
0%
0%
0%
0%
0%
-2,279.9283%
-33,300.6211%
-6,891.7062%
60.3445%
-365.9084%
-428.4651%
-400.5982%
-851.8348%
-729.3621%
-527.6592%
-313.7841%
-15.2255%
-281.1682%
-287.5417%
-648.539%
-875.0988%
-1,570.0197%
-1,610.6719%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.